Coxsackievirus A16 (CA16) Virus-Like Particles (VLPs)

  • 1.00 Dollar US$
  • Published date: September 6, 2019
    • Shirley, New York, United States

Creative Biolabs spends long-term commitment to develop excellent-quality coxsackievirus A16 (CA16) virus-like particles (VLPs). https://www.creative-biolabs.com/coxsackievirus-a16-ca16-virus-like-particles-vlps.html

Result 0 votes
Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Virus-Like Particles (VLPs) for Delivery System

    Virus-Like Particles (VLPs) for Delivery System

    Drug Development Shirley (New York) September 6, 2019 1.00 Dollar US$

    Creative Biolabs has long time been the world-leading provider of virus-like particles (VLPs)-based delivery systems. https://www.creative-biolabs.com/virus-like-particles-vlps-for-delivery-system.html

  • Virus-Like Particles (VLPs) for Vaccine Development

    Virus-Like Particles (VLPs) for Vaccine Development

    Drug Development Shirley (New York) September 6, 2019 1.00 Dollar US$

    Creative Biolabs has been dedicated to leveraging extensive efforts in development of virus-like particles (VLPs)-based vaccines. https://www.creative-biolabs.com/virus-like-particles-vlps-for-vaccine-development.html

  • Virus-Like Particles (VLPs) for Vaccine Development

    Virus-Like Particles (VLPs) for Vaccine Development

    Drug Development Shirley (New York) September 6, 2019 1.00 Dollar US$

    Creative Biolabs has been dedicated to leveraging extensive efforts in development of virus-like particles (VLPs)-based vaccines. https://www.creative-biolabs.com/virus-like-particles-vlps-for-vaccine-development.html